Home

Cronos Group Inc. - Common Share (CRON)

1.8300
-0.0200 (-1.08%)

Cronos Group is a leading global cannabinoid company focused on the research, development, and production of smoked and non-smoked cannabis products

The company operates multiple brands and offers a wide range of cannabis-based products, including oils, capsules, and edibles, catering to both medicinal and recreational markets. Cronos Group is committed to innovative research and development efforts aimed at advancing the cannabis industry, and it emphasizes sustainability and compliance with regulatory standards across its operations. By leveraging strategic partnerships and investments in technology, the company seeks to enhance its market presence and drive growth in the evolving landscape of cannabis consumption.

SummaryNewsPress ReleasesChartHistoricalFAQ
Previous Close1.850
Open1.840
Bid1.830
Ask1.840
Day's Range1.830 - 1.870
52 Week Range1.820 - 3.140
Volume488,289
Market Cap680.40M
PE Ratio (TTM)15.25
EPS (TTM)0.1
Dividend & YieldN/A (N/A)
1 Month Average Volume1,613,136

News & Press Releases

Cronos Appoints Anna Shlimak as Chief Financial Officer
TORONTO, March 19, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”), an innovative global cannabinoid company, today announced the appointment of Anna Shlimak as Chief Financial Officer, effective today. Ms. Shlimak, who previously served as Cronos’ Chief Strategy Officer, will succeed James Holm who is stepping down to pursue other opportunities and will remain with the Company through April 18, 2025 to ensure a seamless transition.
By Cronos Group Inc. · Via GlobeNewswire · March 19, 2025
Delays in Launching Delaware Adult-Use Marijuana Sales are Frustrating Entrepreneurs, Advocates
Entrepreneurs in Delaware are growing increasingly frustrated with the state’s slow rollout of recreational cannabis sales. Although Delaware legalized recreational marijuana in 2023 and was expected to launch sales this spring, several obstacles have put the launch on hold.
Via CannabisNewsWire · March 18, 2025
Delays in Launching Delaware Adult-Use Marijuana Sales are Frustrating Entrepreneurs, Advocates
Entrepreneurs in Delaware are growing increasingly frustrated with the state’s slow rollout of recreational cannabis sales. Although Delaware legalized recreational marijuana in 2023 and was expected to launch sales this spring, several obstacles have put the launch on hold.
Via Investor Brand Network · March 18, 2025
The Canadian Cannabis Report - Monday, March 17talkmarkets.com
The past, present and future of the Canadian cannabis sector.
Via Talk Markets · March 17, 2025
Earnings Scheduled For February 27, 2025benzinga.com
Via Benzinga · February 27, 2025
Top Picks 2025: Altria Grouptalkmarkets.com
Income investors looking for a high dividend stock for 2025 should consider Altria Group Inc. The company has a long history of reliable dividend hikes.
Via Talk Markets · January 15, 2025
420 with CNW — Texas Senators Consider an Outright THC Ban
A Senate committee in Texas recently reviewed a proposed measure that seeks to prohibit all types of THC. SB 3, supported by Lieutenant Governor Dan Patrick, addresses concerns over illegal THC products being sold statewide.
Via CannabisNewsWire · March 10, 2025
420 with CNW — Texas Senators Consider an Outright THC Ban
A Senate committee in Texas recently reviewed a proposed measure that seeks to prohibit all types of THC. SB 3, supported by Lieutenant Governor Dan Patrick, addresses concerns over illegal THC products being sold statewide.
Via Investor Brand Network · March 10, 2025
Cronos Group Inc. to Speak at the 37th Annual Roth Conference
TORONTO, March 10, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”), an innovative global cannabinoid company, today announced that Mike Gorenstein, Chairman, President and CEO, will speak at the 37th Annual Roth Conference on Monday, March 17, 2025, at 1:00 PM PT.
By Cronos Group Inc. · Via GlobeNewswire · March 10, 2025
Big Tobacco's Latest $86.8 Million Cannabis Investment Signals Growing Industry Influencebenzinga.com
British American Tobacco finalizes a C$124.6M investment in Organigram, reinforcing big tobacco's stake in cannabis.
Via Benzinga · March 5, 2025
This Week In Cannabis: Big Earnings Reports, Ice Cube's New Brand, Trump's Mixed Signals, Germany's Import Boom And Much Morebenzinga.com
This week in cannabis news: major acquisitions, regulatory battles, earnings rallies and Ice Cube's new brand launch.
Via Benzinga · March 2, 2025
Cronos Group (CRON) Q4 2024 Earnings Call Transcriptfool.com
CRON earnings call for the period ending December 31, 2024.
Via The Motley Fool · February 27, 2025
420 with CNW — Crackdowns by Oklahoma Authorities Don’t Seem to Be Slowing Illicit Marijuana Operations
For years, Darrin Varnell, Pawnee County Sheriff, had received alarming reports about a cannabis farm near Maramec—men carrying assault rifles, a worker fleeing in fear, and even an incident where a man with a machete chased a naked woman.
Via Investor Brand Network · February 27, 2025
420 with CNW — Crackdowns by Oklahoma Authorities Don’t Seem to Be Slowing Illicit Marijuana Operations
For years, Darrin Varnell, Pawnee County Sheriff, had received alarming reports about a cannabis farm near Maramec—men carrying assault rifles, a worker fleeing in fear, and even an incident where a man with a machete chased a naked woman.
Via CannabisNewsWire · February 27, 2025
Cronos Q4 Sales Jump 27% On Higher Cannabis Flower And Extract Sales, Reports Improved Profitabilitybenzinga.com
Cronos' Q4 sales rose to $30.3M but missed estimates. Gross profit surged, and adjusted EBITDA loss improved as the company eyes long-term growth.
Via Benzinga · February 27, 2025
Cannabis Stocks Cronos, Trulieve, Green Thumb, Verano Trading Up After Earnings: A Full Recapbenzinga.com
Why cannabis stocks Cronos, Verano, Trulieve and Green Thumb stocks gained on Thursday. A look at their Q4 earnings, market drivers and future outlook.
Via Benzinga · February 27, 2025
Cronos Group Reports 2024 Fourth Quarter and Full-Year Results
Net revenue in Q4 2024 increased by 27% year-over-year to $30.3 million; Net revenue in FY 2024 increased by 35% year-over-year to $117.6 million
By Cronos Group Inc. · Via GlobeNewswire · February 27, 2025
Cronos Group Inc. to Hold 2024 Fourth Quarter and Full-Year Earnings Conference Call on February 27, 2025
TORONTO, Feb. 24, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) will hold its 2024 fourth-quarter and full-year earnings conference call on Thursday, February 27, 2025 at 8:30 a.m. ET. Cronos’ senior management team will discuss the Company’s financial results and will be available for questions from the investment community after prepared remarks.
By Cronos Group Inc. · Via GlobeNewswire · February 24, 2025
Illinois Recorded $2bn in Cannabis Sales in 2024
The Illinois Department of Revenue has revealed that the Buckeye State generated over $2 billion in legal cannabis sales and almost $500m in tax revenue last year. Illinois legalized recreational cannabis use on January 1, 2020, becoming the 11th state to allow adult-use cannabis and the first state to legalize the controversial drug via a state legislature instead of a ballot initiative.
Via CannabisNewsWire · February 14, 2025
Illinois Recorded $2bn in Cannabis Sales in 2024
The Illinois Department of Revenue has revealed that the Buckeye State generated over $2 billion in legal cannabis sales and almost $500m in tax revenue last year. Illinois legalized recreational cannabis use on January 1, 2020, becoming the 11th state to allow adult-use cannabis and the first state to legalize the controversial drug via a state legislature instead of a ballot initiative.
Via Investor Brand Network · February 14, 2025
420 with CNW — Colorado Springs Residents Sue City Over Vote to Repeal Recreational Marijuana
Two residents of Colorado Springs have taken legal action against the city over an upcoming ballot initiative in April that seeks to overturn a voter-approved policy permitting recreational cannabis sales.
Via CannabisNewsWire · February 5, 2025
Why Aurora Cannabis Stock Is Skyrocketing Wednesday: What About Canopy, Tilray, Cronos?benzinga.com
Aurora Cannabis (NASDAQ: ACB) surged 45% after reporting record earnings, boosting CGC, TLRY, and CRON stocks.
Via Benzinga · February 5, 2025
420 with CNW — Arkansas Governor Says Medical Cannabis Taxes Will Help Feed Children
Gov. Sarah Huckabee Sanders of Arkansas recently highlighted the advantages of medical cannabis tax revenue in her last week’s State of the State address, announcing a significant plan.
Via CannabisNewsWire · January 27, 2025
420 with CNW — Governor Wants Wisconsin Voters to Legalize Marijuana as GOP Lawmakers Block Reform Efforts
Wisconsin governor Tony Evers has proposed granting voters the power to introduce binding questions directly on the ballot to enact new laws. He cited widespread bipartisan support for issues like cannabis legalization, which the Republican-led legislature has consistently refused to address.
Via CannabisNewsWire · January 14, 2025
Bullish Wednesday For Marijuana Stocks - Cara Therapeutics, MPX International Among Top Gainersbenzinga.com
Via Benzinga · January 1, 2025